Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALL-MB 2008 for Childhood Acute Lymphoblastic Leukemia
NCT01953770Phase 3Unknown
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Feb 2008
- Primary completion
- Jan 2015
- Modality
- Therapeutic Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Status: unknown.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01953770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01953770.